Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system-Reference-Cited by-同舟云学术

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Published:2020-09 Issue: Volume:159 Page:104960
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Yuan Shuofeng,Chan Jasper F.W.,Chik Kenn K.H.,Chan Chris C.Y.,Tsang Jessica O.L.,Liang Ronghui,Cao Jianli,Tang Kaiming,Chen Lin-Lei,Wen Kun,Cai Jian-Piao,Ye Zi-Wei,Lu Gang,Chu Hin,Jin Dong-Yan,Yuen Kwok-Yung

Funder

Health@InnoHK

Innovation and Technology Commission

The Government of the Hong Kong Special Administrative Region of the People’s Republic of China

National Program on Key Research Project of China

Theme-Based Research Scheme

Research Grants Council, Hong Kong Special Administrative Region; and the High Level-Hospital Program

Health Commission of Guangdong Province, China

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Interspecies transmission and emergence of novel viruses: lessons from bats and birds;Chan;Trends Microbiol.,2013

2. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection;Cheng;Clin. Microbiol. Rev.,2007

3. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease;Chan;Clin. Microbiol. Rev.,2015

4. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

5. Coronavirus Disease 2019 (COVID-19) Situation Report – 77;World Health Organization,2020

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 drug discovery and treatment options;Nature Reviews Microbiology;2024-04-15

2. Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent;BioMetals;2024-04-05

3. Potential Use of ChatGPT in Responding to Patient Questions and Creating Patient Resources;JMIR Dermatology;2024-03-06

4. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex;ACS Infectious Diseases;2023-10-28

5. Lessons Learned From Limited Overlap of 15 In Vitro COVID-19 Drug Repurposing Screens;Health Security;2023-08-01